| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Carboplatin 150mg/15ml |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Pfizer |
Amlodipine besylate 5mg
|
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Wilson Pharmaceuticals |
Amlodipine besylate 10mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Content | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Etrombopag olamine product ingredient for etrombopag. It is used to treat low blood platelet counts in adults with chronic immune , thrombocytopenia or aplastic anemia. | Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
| Amlodipine is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years and older. It is also used to treat certain types of angina (chest pain) and coronary artery disease (narrowing of the blood vessels that supply blood to the heart) | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. |
Reviews
There are no reviews yet.